<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30005">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01766817</url>
  </required_header>
  <id_info>
    <org_study_id>IM136-003</org_study_id>
    <nct_id>NCT01766817</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis</brief_title>
  <official_title>Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bristol-Myers Squibb</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once
      daily or 600 mg twice daily for 26 weeks compared with placebo will reduce the decline in
      forced vital capacity (FVC) and will be well tolerated in subjects with idiopathic pulmonary
      fibrosis (IPF).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Rate of change in forced vital capacity (FVC)</measure>
    <time_frame>26 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compare BMS-986020 600 mg once daily or BMS-986020 600 mg twice daily, vs. placebo.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>26 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Safety will be measured based on AEs, vital signs, and clinical laboratory tests.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Arm 1: BMS 986020, 600 mg. once daily</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BMS-986020, 600 mg tablets, by mouth, once daily, 26 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: BMS-986020, 600 mg twice daily</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BMS-986020, 600 mg tablets, by mouth, twice daily, 26 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3: Placebo matching with  BMS-986020</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo, 0 mg tablets,  by mouth,  twice daily, 26 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BMS-986020</intervention_name>
    <arm_group_label>Arm 1: BMS 986020, 600 mg. once daily</arm_group_label>
    <arm_group_label>Arm 2: BMS-986020, 600 mg twice daily</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo matching with BMS-986020</intervention_name>
    <arm_group_label>Arm 3: Placebo matching with  BMS-986020</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Are between the ages of 40 and 90 years, inclusive, at randomization.

          -  Have clinical symptoms consistent with IPF.

          -  Have first received a diagnosis of IPF less than 6 years before randomization. The
             date of diagnosis is defined as the date of the first available imaging or surgical
             lung biopsy consistent with IPF/UIP.

          -  Have a diagnosis of usual interstitial pulmonary fibrosis (UIP) or IPF by HRCT or
             surgical lung biopsy (SLB)

          -  Extent of fibrotic changes (honeycombing, reticular changes) greater than the extent
             of emphysema on HRCT scan.

          -  Have no features supporting an alternative diagnosis on transbronchial biopsy,BAL, or
             SLB, if performed.

          -  Have percent predicted post-bronchodilator FVC between 50% and 90%, inclusive, at
             screening.

          -  Have a change in post-bronchodilator FVC (measured in liters) between screening and
             day 1 that is less than a 10% relative difference, calculated as: the absolute value
             of 100% * (screening FVC (L) - day 1 FVC (L)) / screening FVC(L).

          -  Have carbon monoxide diffusing capacity (DLCO) between 30% and 80% (adjusted for
             hemoglobin and altitude, inclusive, at screening.

          -  Have no evidence of improvement in measures of IPF disease severity over the
             preceding year, in the investigator's opinion.

          -  Be able to walk 150 meters or more during the  6 minute walk test (6MWT) at
             screening.

          -  Demonstrate a decrease in oxygen saturation of 2 percentage points or greater during
             the 6MWT at screening (may be performed with supplemental oxygen titrating to keep
             oxygen saturation levels &gt;88%).

          -  Are able to understand and sign a written informed consent form.

          -  Are able to understand the importance of adherence to study treatment and the study
             protocol and are willing to comply with all study requirements, including the
             concomitant medication restrictions, throughout the study.

          -  Women of childbearing potential (WOCBP)and men who are sexually active with WOCBP
             must use acceptable method(s) of contraception.

        Exclusion Criteria:

          -  Target Disease Exclusions

               1. Has significant clinical worsening of IPF between screening and day 1 (during
                  the screening process), in the opinion of the investigator.

               2. Has forced expiratory volume in 1 second (FEV1)/FVC ratio less than 0.8 after
                  administration of bronchodilator at screening.

               3. Has bronchodilator response, defined by an absolute increase of 12% or greater
                  and an increase of 200 mL in FEV1 or FVC or both after bronchodilator use
                  compared with the values before bronchodilator use at screening.

          -  Medical History and Concurrent Diseases

               1. Has a history of clinically significant environmental exposure known to cause
                  pulmonary fibrosis.

               2. Has a known explanation for interstitial lung disease.

               3. Has a clinical diagnosis of any connective tissue disease.

               4. Currently has clinically significant asthma or chronic obstructive pulmonary
                  disease.

               5. Has clinical evidence of active infection.

               6. Has any history of malignancy likely to result in significant disability or
                  likely to require significant medical or surgical intervention within the next 2
                  years. This does not include minor surgical procedures for localized cancer
                  (e.g., basal cell carcinoma).

               7. Has any condition other than IPF that, in the opinion of the investigator, is
                  likely to result in the death of the subject within the next 2 years.

               8. Has a history of end-stage liver disease.

               9. Has a history of end-stage renal disease requiring dialysis.

              10. Has a history of unstable or deteriorating cardiac or pulmonary disease (other
                  than IPF) within the previous 6 months.

              11. Has a history of alcohol or substance abuse in the past 2 years.

              12. Has a family or personal history of long QT syndrome and/or Torsades de Pointes
                  (polymorphic ventricular tachycardia).

              13. Unable to discontinue certain CYP2C8, CYP2C9, and OATP1B1
                  substrates/inhibitors/inducers within 7 days of screening.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bristol-Myers Squibb</last_name>
    <role>Study Director</role>
    <affiliation>Bristol-Myers Squibb</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham - Division of Pulmonary, Allergy &amp; Criticial Care</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294-0006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Misty Purser</last_name>
      <phone>205-934-5573</phone>
      <email>mlpurser@uab.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital and Medical Center - Heart Lung Institute/ Clinical Research</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgann Vanderjagt</last_name>
      <phone>602-406-3825</phone>
      <email>georgann.vanderjagt@dignityhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSD Health System</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chris Whitehead</last_name>
      <phone>858-657-5498</phone>
      <email>chwhitehead@ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Jackman</last_name>
      <phone>310-423-4765</phone>
      <email>susan.jackman@cshs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>David Geffen School of Medicine at UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eileen Callahan</last_name>
      <phone>310-794-2466</phone>
      <email>ecallahan@mednet.ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California at San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Archer Eller</last_name>
      <phone>415-502-1958</phone>
      <email>archer.eller@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305-5236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan S. Jacobs</last_name>
      <phone>650-725-8083</phone>
      <email>ssjpulm@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly McPeak</last_name>
      <phone>303-398-1708</phone>
      <email>mcpeakk@njhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine, Section of Pulmonary &amp; Critical Care</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Estrom</last_name>
      <phone>203-785-7324</phone>
      <email>jean.estrom@yale.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bay Area Chest Physicians/Research Alliance, Inc.</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Persechino</last_name>
      <phone>727-631-0779</phone>
      <email>frank@researchalliance.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Pulmonary &amp; Sleep Research Institute of Florida</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauraine Crandall</last_name>
      <phone>336-677-6672</phone>
      <email>cardioinc2@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610-0225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elaine Davis</last_name>
      <phone>352-273-8666</phone>
      <email>barbara.davis@medicine.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ILD Research Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuelle Simonet</last_name>
      <phone>305-243-3728</phone>
      <email>esimonet@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida- Weston Hospital</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Calvin Killinbeck</last_name>
      <phone>954-659-6247</phone>
      <email>killinc@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Pulmonary Research Institute</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Only</last_name>
      <phone>407-740-8078</phone>
      <email>only@fcpresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Spring Holland</last_name>
      <phone>773-834-4053</phone>
      <email>sholland@bsd.uchicago.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Via Christi Clinic</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67028</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Vincent</last_name>
      <phone>316-689-9542</phone>
      <email>angela.vincent@viachristi.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamra Perez</last_name>
      <phone>502-852-1358</phone>
      <email>tamra.perez@louisville.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tulane University</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Ditta</last_name>
      <phone>504-988-4040</phone>
      <email>Sditta@tulane.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kristen Lingle</last_name>
      <phone>504-988-2325</phone>
      <email>Klingle@tulane.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leena Mathew</last_name>
      <phone>410-550-2062</phone>
      <email>lmathew@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda H. Demersky</last_name>
      <phone>617-667-4905</phone>
      <email>ahapgood@bidmc.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Smith</last_name>
      <phone>617-525-9297</phone>
      <email>msmith67@partners.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candace Flaherty</last_name>
      <phone>734-936-8301</phone>
      <email>cflah@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tommy Goodwin</last_name>
      <phone>612-625-7719</phone>
      <email>goodw020@umn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic, Pulmonary Clinical Research Unit</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue M. Walsh</last_name>
      <phone>507-293-0637</phone>
      <email>walsh.suson@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CardioPulmonary Research Center</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Crocker</last_name>
      <phone>314-439-5864</phone>
      <email>jennifer.crocker@stlukes-stl.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aviva Aloush</last_name>
      <phone>314-747-1931</phone>
      <email>alousha@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy A. Dickie</last_name>
      <phone>603-650-4711</phone>
      <email>kathy.a.dickie@hitchcock.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pulmonary &amp; Allergy Associates, PA</name>
      <address>
        <city>Summit</city>
        <state>New Jersey</state>
        <zip>07901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marissa Rienton-Lim</last_name>
      <phone>908-934-0440</phone>
      <phone_ext>1902</phone_ext>
      <email>marissar@paamds.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ISA Clinical Research</name>
      <address>
        <city>Forest Hills</city>
        <state>New York</state>
        <zip>11375</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Cervellione</last_name>
      <phone>888-795-5255</phone>
      <phone_ext>811</phone_ext>
      <email>kcervellione@isaclinicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Moll</last_name>
      <phone>646-962-2672</phone>
      <email>chm2044@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Highland Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14620</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Lyda</last_name>
      <phone>585-341-6774</phone>
      <email>elizabeth_lyda@urmc.rochester.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asheville Pulmonary and Critical Care Associates, P.A.</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Shelton</last_name>
      <phone>828-225-5241</phone>
      <email>kshelton@ashevillepulmonary.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Foss, Site 1002</last_name>
      <phone>919-613-6246</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Pulmonary, Critical Care &amp; Sleep Medicine</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Ingledue</last_name>
      <phone>513-558-0027</phone>
      <email>rebecca.ingledue@uc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Wehrmann</last_name>
      <phone>216-445-0574</phone>
      <email>wehrmar@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachael Compton</last_name>
      <phone>614-336-2361</phone>
      <email>rachael.compton@osumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan Kessler</last_name>
      <phone>503-494-9570</phone>
      <email>breathe@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Oregon Clinic</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arlena Loos</last_name>
      <phone>503-963-3183</phone>
      <email>aloos@orclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Temple Lung Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvia Johnson</last_name>
      <phone>215-707-9842</phone>
      <email>sylvia.johnson@tuhs.temple.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jadeen Rosenthal</last_name>
      <phone>215-662-6280</phone>
      <email>jadeen.rosenthal@uphs.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center - Simmons Center for Interstitial Lung Disease</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle MacPherson</last_name>
      <phone>412-647-4537</phone>
      <email>macphersonmj@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen J Kinser</last_name>
      <phone>615-343-7068</phone>
      <email>kathleen.j.kinser@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Wendi Mason</last_name>
      <phone>615-343-7068</phone>
      <email>wendi.mason@Vanderbilt.Edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center - Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>78212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Quivers</last_name>
      <phone>214-645-6489</phone>
      <email>jacqueline.quivers@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metroplex Pulmonary and Sleep Center</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75069</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rupa Krishna</last_name>
      <phone>972-838-1892</phone>
      <email>rkrishna@mpsleepcenter.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alamo Clinical Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Phillips</last_name>
      <phone>210-223-3010</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Tyler</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Hoeft</last_name>
      <phone>903-877-5518</phone>
      <email>janice.hoeft@uthct.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Spencer Whipple</last_name>
      <phone>801-581-5864</phone>
      <email>spencer.whipple@hsc.utah.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vermont Lung Center</name>
      <address>
        <city>Colchester</city>
        <state>Vermont</state>
        <zip>05444</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth A. Reilly</last_name>
      <phone>802-847-2160</phone>
      <email>beth.reilly@vtmednet.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MultiCare Pulmonary Specialists</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Edwards</last_name>
      <phone>253-403-0366</phone>
      <email>tiffany.edwards@multicare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospital &amp; Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tonia Qaisar</last_name>
      <phone>608-262-3456</phone>
      <email>tqaisar@clinicaltrials.wisc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>January 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IPF</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
